Importantly, we find that BET inhibitors disrupt the PTF-Jun CRC and re-sensitizes PDAC cells to Yap blockade, illustrating the therapeutic potential of combining Yap and BET inhibitors for the treatment of PDAC. The gene discussed is DNER; the disease is colorectal carcinoma.